Predictive value of combined estimated plasma volume status and neutrophil-to-lymphocyte ratio for cardiovascular mortality in patients with acute myocardial infarction with heart failure
Authors:
Open Access
- 28 September 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1948520
Abstract
Objective: Estimated plasma volume status (ePVS) and neutrophil-to-lymphocyte ratio (NLR) are novel biomarkers reflecting hemodynamic load and systemic inflammatory immune status, respectively. This study aimed to explore the prognostic value of combined ePVS and NLR for cardiovascular mortality in patients with heart failure (HF) complicating acute myocardial infarction (AMI). Methods: This retrospective observational study consecutively enrolled patients diagnosed with AMI complicated by HF at Putian University Affiliated Hospital from January 2020 to June 2024. Admission hemoglobin and hematocrit levels were used to calculate ePVS, while routine blood test parameters were applied to determine NLR. The primary endpoint was cardiovascular mortality within two years after AMI. Cox proportional hazards regression models were constructed to analyze the associations of ePVS and NLR with clinical endpoints. The predictive efficacy of single and combined ePVS and NLR was comprehensively evaluated using the area under the receiver operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). Results: A total of 2046 patients were ultimately included. During a mean follow-up of 819 days, endpoint events occurred in 14.90% of the study population. Univariate Cox regression analysis demonstrated that ePVS served as a strong risk factor for cardiovascular mortality (HR = 1.571, 95% CI: 1.502–1.642, P < 0.001). After adjusting for age, diabetes mellitus, hypertension, atrial fibrillation, and NLR, both ePVS (HR = 1.436, 95% CI: 1.370–1.505, P < 0.001) and NLR (HR = 1.330, 95% CI: 1.258–1.406, P < 0.001) remained independent predictors of cardiovascular mortality. The combined predictive model integrating ePVS and NLR exhibited significantly superior predictive performance compared with either biomarker alone (AUC: 0.794 for ePVS vs. 0.891 for ePVS + NLR, P < 0.001). Both NRI and IDI analyses further verified the significant improvement in predictive accuracy of the combined model (all P < 0.01). Conclusion: ePVS and NLR represent valuable prognostic biomarkers for cardiovascular mortality in AMI patients. The combination of ePVS and NLR significantly improves predictive performance and facilitates precise risk stratification.Keywords
This publication has 21 references indexed in Scilit:
- TRIM21 exacerbates hypoxia-induced cardiomyocyte Pyroptosis through GSDMD ubiquitination in post-myocardial infarction heart failureInternational Immunopharmacology, 2025
- Prevention of heart failure after acute myocardial infarctionThe Lancet, 2025
- Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size mattersEuropean Journal of Heart Failure, 2024
- Prognostic Value of Estimated Plasma Volume Status at Discharge in Acute Myocardial InfarctionESC Heart Failure, 2024
- Inflammation in heart failure: pathophysiology and therapeutic strategiesInflammation Research, 2024
- Heart Failure After Myocardial Infarction: Glass Emptier than FullEuropean Journal of Heart Failure, 2023
- Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarctionIJC Heart & Vasculature, 2021
- Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunitiesPharmacology & Therapeutics, 2018
- Post-Myocardial Infarction Heart FailureJACC: Heart Failure, 2018
- The myocardial matrix and the development and progression of ventricular remodelingCurrent Cardiology Reports, 2000